The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference39 articles.
1. Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme;EE Zijlstra;PLoS Negl Trop Dis
2. Clinical and Immunological Aspects of Post-Kala-Azar Dermal Leishmaniasis in Bangladesh;S Islam;Am J Trop Med Hyg,2013
3. Post kala-azar dermal leishmaniasis: New observations challenge previous assumptions;ICDDR,B Heal Sci Bull,2007
4. Inefectivity of Post-Kala-azar Dermal Leishmaniasis patients to sand flies: revisiting a Proof of Concept in the context of the Kala-azar Elimination Program in the Indian subcontinent;R Molina;Clin Infect Dis,2017
5. Miltefosine—discovery of the antileishmanial activity of phospholipid derivatives;SL Croft;Trans R Soc Trop Med Hyg,2006
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL);Experimental Parasitology;2024-02
2. Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study;PLOS Neglected Tropical Diseases;2023-11-21
3. Vaccine value profile for leishmaniasis;Vaccine;2023-11
4. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;2023-09-07
5. Effective immuno-therapeutic treatment of Canine Leishmaniasis;PLOS Neglected Tropical Diseases;2023-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3